Results 31 to 40 of about 1,682,882 (302)

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

New England Journal of Medicine, 2013
BACKGROUND The cardiovascular safety and efficacy of many current antihyperglycemic agents, including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear.
B. Scirica, Deepak L. Bhatt, E. Braunwald, P. Steg, J. Davidson, B. Hirshberg, P. Ohman, R. Frederich, S. Wiviott, Elaine B. Hoffman, M. Cavender, J. Udell, N. Desai, Ofri Mosenzon, Darren K Mcguire, K. Ray, Lawrence A Leiter, I. Raz   +17 more
semanticscholar   +1 more source

Factors Associated with Preventive Practices of Type 2 Diabetes Mellitus

Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education, 2021
Background: Diabetes mellitus is a non-communicable disease that can be prevented by controlling the risk factors. Diabetes mellitus prevention practice is important so that prevention of type 2 diabetes mellitus can be carried out effectively. There are
Nissa Kusariana, Tutut Okta Hardiyanti, Moh. Arie Wurjanto   +2 more
doaj   +1 more source

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

New England Journal of Medicine, 2019
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...
V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey   +23 more
semanticscholar   +1 more source

Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature

Diabetes & vascular disease research, 2021
Type 2 diabetes mellitus is a pathology of heterogeneous etiology characterized by hyperglycemia resulting from lack of insulin action, insulin secretion, or both, and the population with diabetes mellitus is predicted to be about 439 million worldwide ...
Sopida Thipsawat
semanticscholar   +1 more source

Facilitators and barriers of adaptation to diabetes: experiences of Iranian patients [PDF]

, 2014
Background: Diabetes mellitus is one of the most challenging and burdensome chronic diseases of the 21st century and More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year.
Arshadi Bostanabad, M., Jouybari, L., Karimi Moonaghi, H., McDonald, H., Namdar Areshtanab, H.   +4 more
core   +2 more sources

Vitamins and Type 2 Diabetes Mellitus [PDF]

Endocrine, Metabolic & Immune Disorders-Drug Targets, 2015
The present review evaluates the relationship between type 2 diabetes mellitus and individual or combined vitamins. Antioxidant vitamins A, C and E are found decreased in diabetic subjects, possibly due to an increased need to control the excessive oxidative stress produced by abnormalities in glucose metabolism.
Martínez-Carrillo Beatriz Elina, Benítez-Arciniega Alejandra Donají, Guadarrama-López Ana Laura, Roxana Valdés-Ramos   +3 more
openaire   +3 more sources

Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar

Journal of Diabetes Investigation, 2021
Aims/Introduction To study the epidemiology, genetic landscape and causes of childhood diabetes mellitus in the State of Qatar. Materials and methods All patients (aged 0–18 years) with diabetes mellitus underwent biochemical, immunological and genetic ...
Basma Haris, Saras Saraswathi, Sara Al‐Khawaga, Reem Hasnah, Amira Saeed, Shihab Mundekkadan, Noor Hamed, Houda Afyouni, Tasneem Abdel‐Karim, Shayma Mohammed, Amel Khalifa, Maryam Al‐Maadheed, Mahmoud Al‐Zyoud, Ahmed Shamekh, Ahmed Elawwa, Fawziya Al‐Khalaf, Sabri Boughorbel, Goran Petrovski, Khalid Hussain   +18 more
doaj   +1 more source

GAMBARAN POLA MAKAN PASIEN DIABETES MELLITUS TIPE 2 [PDF]

, 2023
Background: Diabetes Mellitus (DM) is a disease caused by a decrease in insulin production due to lack of functioning of the pancreas, resulting in an increase in blood sugar levels in the body.
Anggraini, Sindi Meita
core  

Colesevelam for type 2 diabetes mellitus [PDF]

Cochrane Database of Systematic Reviews, 2011
Colesevelam is a second-generation bile acid sequestrant that has effects on both blood glucose and lipid levels. It provides a promising approach to glycaemic and lipid control simultaneously.To assess the effects of colesevelam for type 2 diabetes mellitus.Several electronic databases were searched, among these The Cochrane Library (Issue 1, 2012 ...
Cheow Peng Ooi, Seng Cheong Loke
openaire   +3 more sources

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

Endocrine reviews, 2016
The steep rise of type 2 diabetes mellitus (T2DM) and associated complications go along with mounting evidence of clinically important sex and gender differences.
A. Kautzky-Willer, J. Harreiter, G. Pacini   +2 more
semanticscholar   +1 more source